Monitoring the occurrence of emerging forms of Creutzfeldt-Jakob disease in the United States

Neurology

Volumn 60, Issue 2, 2003, Pages 176-181

  Belay, Ermias D ^a,c   Maddox, Ryan A ^a   Gambetti, Pierluigi ^b   Schonberger, Lawrence B ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c Mailstop A 39 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; EPIDEMIC; EUROPE; HEALTH PROGRAM; HUMAN; ISRAEL; JAPAN; MONITORING; NEUROPATHOLOGY; PRION DISEASE; PRIORITY JOURNAL; REVIEW; UNITED STATES;

EID: 0037469196     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000036913.87823.D6     Document Type: Review

References (50)

1. Belay ED. Transmissible spongiform encephalopathies in humans. Annu Rev Microbiol 1999;53:283-314.
2. Brown P, Preece M, Brandel JP, et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000;55:1075-1081.
3. Fradkin JE, Schonberger LB, Mills JL, et al. Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States. JAMA 1991;265:880-884.
4. Centers for Disease Control and Prevention. Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts - Japan, January 1979-May 1996. MMWR Morb Mortal Wkly Rep 1997;46:1066-1069.
5. Belay ED, Gambetti P, Schonberger LB, et al. Creutzfeldt-Jakob disease in unusually young patients who consumed venison. Arch Neurol 2001;58:1673-1678.
6. Laplanche JL, Hunter N, Shinagawa M, Williams E. Scrapie, chronic wasting disease, and transmissible mink encephalopathy. In: Prusiner SB, ed. Prion biology and diseases. Cold Spring, NY: Cold Spring Laboratory Press, 1999;393-429.
7. Southeastern Cooperative Wildlife Disease Study, College of Veterinary Medicine, The University of Georgia. Special CWD issue. SCWDS Briefs 2002;18:1-17.
8. Cohen CH, Valleron AJ. When did bovine spongiform encephalopathy (BSE) start? Implications on the prediction of a new variant of Creutzfeldt-Jakob disease (vCJD) epidemic. Int J Epidemiol 1999;28:526-531.
9. Department of Environment, Food and Rural Affairs, United Kingdom. BSE. Available at: http://www.defra.gov.uk/animalh/bse/index.html. Accessed October 29, 2002.
10. Anderson RM, Donnelly CA, Ferguson NM, et al. Transmission dynamics and epidemiology of BSE in British cattle. Nature 1996;382:779-788.
11. Collee JG, Bradley R. BSE: a decade on - part 1. Lancet 1997;349:636-641.
12. Brown P, Will RG, Bradley R, Asher DM, Detwiler L. Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: background, evolution, and current concerns. Emerg Infect Dis 2001;7:6-16.
13. Collee JG, Bradley R. BSE: a decade on - part 2. Lancet 1997;349:715-721.
14. Office International Des Epizooties. Number of reported cases of bovine spongiform encephalopathy (BSE) worldwide. Available at: http://www.oie.int/eng/info/en_esbmonde.htm. Accessed April 1, 2002.
15. European Commission. Available at: http://www.europa.eu.int/eur-lex/en/com/paf/2000/en_500PC0820.html. Accessed October 29, 2002.
16. U.S. Department of Agriculture, Animal and Plant Health Inspection Service. BSE surveillance. Available at: http: //www.aphis.usda.gov/oa/bse/bsesurvey.pafl#charts. Accessed July 19, 2002.
17. Nightingale SL. Ruminant-to-ruminant feeding ban proposed to reduce risk of transmissible spongiform encephalopathies. JAMA 1997;277:370.
18. Schonberger LB. New variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Infect Dis Clin North Am 1998;12:111-121.
19. Will RG, Ironside JW, Zeidler M, et al. A new variant of CreutzfeldtJakob disease in the UK. Lancet 1996;347:921-925.
20. Department of Health, United Kingdom. Monthly Creutzfeldt-Jakob disease statistics. Available at: http: //www.doh.gov.uk/cjd/stats/oct02.htm. Accessed October 29, 2002.
21. Institut de Veille Sanitaire. Nombre de cas de maladie de Creutzfeldt-Jakob. Available at: http://www.invs.sante.fr/display/?doc=publications/mcj/donnees_mcj.html. Accessed April 8, 2002.
22. Kay R, Lau WY, Ng HK, Chan YL, Lyon DJ, van Hasselt CA. Variant Creutzfeldt-Jakob disease in Hong Kong. Hong Kong Med J 2001;7:296-298.
23. Bruce ME, Will RG, Ironside JW. Transmission to mice indicates that 'new variant' CJD is caused by the BSE agent. Nature 1997;389:498-501.
24. Collinge J, Sidle KCL, Heads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996;383:685-690.
25. Lasmézas CI, Deslys JP, Demaimay R, et al. BSE transmission to macaques. Nature 1996;381:743-744.
26. Scott MR, Will R, Ironside J, et al. Compelling transgenic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci USA 1999;96:15137-15142.
27. Belay ED, Potter ME, Schonberger LB. Relationship between transmissible spongiform encephalopathies in animals and humans. In: Task Force Report of the Council for Agricultural Science and Technology. No. 136. Washington, DC: Council for Agricultural Science and Technology, 2000;20-21.
28. Andrew NJ, Farrington CP, Cousens SN, et al. Incidence of variant Creutzfeldt-Jakob disease in the UK. Lancet 2000;356:481-482.
29. Ghani AC, Ferguson NM, Donnelly CA, Anderson RM. Predicted vCJD mortality in Great Britain. Nature 2000;406:583-584.
30. Valleron AJ, Boelle PY, Will R, Cesbron JY. Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom. Science 2001;294:1726-1728.
31. Huillard d'Aignaux JN, Cousens SN, Smith PG. Predictability of the UK variant Creutzfeldt-Jakob disease epidemic. Science 2001;294:1729-1731.
32. Will RG, Zeidler M, Stewart GE, et al. Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol 2000;47:575-582.
33. Spencer MD, Knight RSG, Will RG. First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case note review of early psychiatric and neurological features. BMJ 2002;324:1479-1482.
34. Zeidler M, Sellar RJ, Collie DA, et al. The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet 2000;355:1412-1418.
35. Ironside JW. Neuropathological findings in new variant CJD and experimental transmission of BSE. FEMS Immunol Med Microbiol 1998;21:91-95.
36. Hill AF, Zeidler M, Ironside J, Collinge J. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 1997;349:99-100.
37. Hill AF, Butterworth RJ, Joiner S, et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999;353:183-189.
38. Parchi P, Capellari S, Chen SG, et al. Typing prion isoforms. Nature 1997;386:232-233.
39. Gore SM, Bingham S, Day NE. Age related dietary exposure to meat products from British dietary surveys of teenagers and adults in the 1980s and 1990s. BMJ 1997;315:404-405.
40. Lorains JW, Henry C, Agbamu DA, et al. Variant Creutzfeldt-Jakob disease in an elderly patient. Lancet 2001;357:1339-1340.
41. Tan L, Williams MA, Khan MK, Champion HC, Nielsen NH. Risk of transmission of bovine spongiform encephalopathy to humans in the United States: report of the council on scientific affairs. JAMA 1999;281:2330-2339.
42. Centers for Disease Control and Prevention. Update 2002: bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease. Available at: http://www.cdc.gov/ncidod/diseases/cjd/cjd.htm. Accessed October 29, 2002.
43. Houston F, Foster JD, Chong A, Hunter N, Bostock CJ. Transmission of BSE by blood transfusion in sheep. Lancet 2000;356:999-1000.
44. Food and Drug Administration. Guidance for industry: revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob disease (CJD) and variant Creutzfeldt-Jakob disease (vCJD) by blood and blood products. Available at: http://www.fda.gov/cber/gdlns/cjdvcjd.pdf. Accessed April 1, 2002.
45. Gibbons RV, Holman RC, Belay ED, Schonberger LB. Creutzfeldt-Jakob disease in the United States: 1979-1998. JAMA 2000;284:2322-2323.
46. Holman RC, Khan AS, Belay ED, Schonberger LB. Creutzfeldt-Jakob disease in the United States, 1979-1994: using national mortality data to assess the possible occurrence of variant cases. Emerg Infect Dis 1996;2:333-337.
47. National Prion Disease Pathology Surveillance Center (homepage). Available at: http://www.cjdsurveillance.com. Accessed April 1, 2002.
48. Hamir AN, Cutlip RC, Miller JM, et al. Preliminary findings on the experimental transmission of chronic wasting disease agent of mule deer to cattle. J Vet Diagn Invest 2001;13:91-96.
49. Raymond GJ, Hope J, Kocisko DA, et al. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature 1997;388:285-288.
50. Raymond GJ, Bossers A, Raymond LD, et al. Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease. EMBO 2000;19:4425-4430.